Pharmafile Logo

rPPG

Indegene acquires healthcare marketing services of Canada-based Aptilon

To provide clients with improved physician engagement strategies

- PMLiVE

Merck raises guidance on solid Q3 sales

Rebif gains boost pharma division

- PMLiVE

EU approval for AZ/BMS’ first-in-class diabetes drug Forxiga

First SGLT2 inhibitor to be approved for marketing anywhere in the world

- PMLiVE

EFPIA says “indiscriminate” data transparency could be harmful

Comments come as European Parliament prepares to discuss clinical trial overhaul

- PMLiVE

Publicis Groupe gives its VivaKi agencies greater autonomy

Move intended to boost Groupe’s digital growth as its third quarter revenues fall

- PMLiVE

A brain of two halves

The commonly held view that a campaign has to deliver cold hard facts with an appealing visual may be an oversimplification…

- PMLiVE

Behavioural economics in pharma

It’s not the answer to life’s big question but gives us the framework we need to understand decision making

- PMLiVE

WHO launches framework to monitor non-communicable diseases

Will measure success of efforts to reduce rates of cancer, diabetes, lung conditions and heart disease

Government accused of blocking patients from drug pricing talks

Coalition of cancer charities calls for a central role in pricing negotiations

Cancer Research UK appoints new head of public affairs and campaigning

Layla Theiner will drive the charity’s public affairs and campaigning activities across the UK and EU

- PMLiVE

Medicines key to new NHS Mandate, says ABPI

Government sets objectives for NHS Commissioning Board to improve patient care in England

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links